Prot #017006: A Phase 2 Study of Lisocabtagene Maraleucel (JCAR017) as Second-Line Therapy in Adult Patients with Aggressive B-cell NHL

Project: Research project

Project Details

StatusActive
Effective start/end date8/8/19 → 8/8/25

Funding

  • DrugDev Inc. (Prot #017006)
  • Juno Therapeutics, Inc. (Prot #017006)